Aleafia Health Announces $6.4M Positive Adjusted EBITDA, $14.6M Net Revenue in Q1 2020

Aleafia Health Announces $6.4M Positive Adjusted EBITDA, $14

$13.7M cannabis net revenue, 183% increase over previous quarter, and 2,486% increase over prior year’s quarterPositive cash flow from operations85% gross margin on cannabis net revenue3% increase SG&A expenses over previous quarter$35M in cash, cash equivalents and marketable securitiesTotal liabilities decline by $7.9 million over Q4 2019Fifth consecutive quarter reporting record revenue, second consecutive quarter of positive adjusted EBITDAAdjusted EBITDA margin of 44%Cash cost to produce per gram of $0.31TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), is pleased to report its financial results for the three months ended March 31, 2020 (“Q1 2020”).Management Commentary
CBJ Newsmakers

Recommended
Telling the Afghanistan war story during COVID-19 through the lens of young Afghan-CanadianArgonaut Gold and Alio Gold Merger: Reminder to Vote